| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Collagen | 162 | 2021 | 2681 | 6.010 |
Why?
|
| Bone Development | 24 | 2019 | 483 | 3.860 |
Why?
|
| Vascular Endothelial Growth Factor A | 29 | 2021 | 3510 | 3.320 |
Why?
|
| Osteogenesis | 27 | 2017 | 1291 | 2.760 |
Why?
|
| Osteoblasts | 23 | 2021 | 1164 | 2.450 |
Why?
|
| Hemangioma | 10 | 2016 | 738 | 2.310 |
Why?
|
| Endostatins | 32 | 2012 | 174 | 2.140 |
Why?
|
| Cartilage | 44 | 2013 | 818 | 1.920 |
Why?
|
| Osteochondrodysplasias | 27 | 2022 | 182 | 1.910 |
Why?
|
| Collagen Type XVIII | 25 | 2013 | 56 | 1.810 |
Why?
|
| Chondrocytes | 19 | 2017 | 804 | 1.620 |
Why?
|
| Cherubism | 10 | 2021 | 16 | 1.600 |
Why?
|
| Extracellular Matrix | 35 | 2021 | 1743 | 1.600 |
Why?
|
| Bone and Bones | 27 | 2021 | 2576 | 1.580 |
Why?
|
| Growth Plate | 14 | 2017 | 274 | 1.390 |
Why?
|
| Cartilage, Articular | 20 | 2017 | 1095 | 1.390 |
Why?
|
| Bone Regeneration | 3 | 2016 | 420 | 1.350 |
Why?
|
| Osteoarthritis | 14 | 2017 | 1035 | 1.330 |
Why?
|
| Collagen Type II | 12 | 2017 | 151 | 1.290 |
Why?
|
| Mesenchymal Stem Cells | 13 | 2015 | 1632 | 1.230 |
Why?
|
| TRPP Cation Channels | 4 | 2014 | 176 | 1.150 |
Why?
|
| Cell Differentiation | 29 | 2017 | 11478 | 1.120 |
Why?
|
| Vascular Endothelial Growth Factors | 8 | 2016 | 771 | 1.090 |
Why?
|
| Palate | 4 | 2012 | 123 | 1.070 |
Why?
|
| Connective Tissue | 7 | 2016 | 415 | 1.070 |
Why?
|
| Palatal Expansion Technique | 3 | 2012 | 25 | 1.060 |
Why?
|
| Animals | 287 | 2021 | 168660 | 1.050 |
Why?
|
| Genes | 24 | 2002 | 1893 | 1.040 |
Why?
|
| Mice | 159 | 2021 | 81154 | 0.990 |
Why?
|
| Endothelial Cells | 14 | 2019 | 3482 | 0.970 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 5 | 2016 | 552 | 0.930 |
Why?
|
| Adipocytes | 4 | 2015 | 1182 | 0.930 |
Why?
|
| Calcification, Physiologic | 7 | 2021 | 169 | 0.880 |
Why?
|
| Cranial Sutures | 4 | 2012 | 93 | 0.870 |
Why?
|
| Osteoclasts | 10 | 2016 | 729 | 0.850 |
Why?
|
| Integrases | 5 | 2017 | 533 | 0.840 |
Why?
|
| Mesoderm | 10 | 2014 | 686 | 0.820 |
Why?
|
| Peptide Fragments | 30 | 2009 | 5096 | 0.810 |
Why?
|
| Signal Transduction | 34 | 2019 | 23398 | 0.810 |
Why?
|
| Adipogenesis | 2 | 2015 | 357 | 0.800 |
Why?
|
| Transcription Factors | 24 | 2019 | 12209 | 0.800 |
Why?
|
| Periodontal Ligament | 3 | 2018 | 118 | 0.780 |
Why?
|
| Plasmodium ovale | 1 | 2020 | 15 | 0.780 |
Why?
|
| Ossification, Heterotopic | 3 | 2015 | 239 | 0.770 |
Why?
|
| X-Ray Microtomography | 4 | 2018 | 428 | 0.770 |
Why?
|
| Anodontia | 4 | 2022 | 49 | 0.770 |
Why?
|
| Heparan Sulfate Proteoglycans | 5 | 2005 | 118 | 0.770 |
Why?
|
| Neovascularization, Pathologic | 16 | 2009 | 2638 | 0.760 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 7 | 2017 | 547 | 0.760 |
Why?
|
| Neovascularization, Physiologic | 13 | 2017 | 1351 | 0.750 |
Why?
|
| Mice, Transgenic | 31 | 2018 | 9731 | 0.740 |
Why?
|
| Tendons | 23 | 2019 | 548 | 0.730 |
Why?
|
| Bone Remodeling | 4 | 2016 | 569 | 0.730 |
Why?
|
| Molecular Sequence Data | 84 | 2015 | 18107 | 0.720 |
Why?
|
| Chromosomes, Human, Pair 6 | 10 | 1997 | 380 | 0.720 |
Why?
|
| Base Sequence | 80 | 2008 | 12798 | 0.710 |
Why?
|
| Myositis Ossificans | 2 | 2011 | 79 | 0.710 |
Why?
|
| Basement Membrane | 12 | 2016 | 357 | 0.710 |
Why?
|
| Amino Acid Sequence | 79 | 2015 | 13809 | 0.690 |
Why?
|
| Procollagen | 18 | 1996 | 185 | 0.690 |
Why?
|
| Proteoglycans | 11 | 2021 | 837 | 0.690 |
Why?
|
| Chromosome Mapping | 35 | 2012 | 4737 | 0.660 |
Why?
|
| Receptors, Peptide | 3 | 2016 | 273 | 0.650 |
Why?
|
| Epithelium | 11 | 2008 | 1679 | 0.640 |
Why?
|
| Sequence Deletion | 12 | 2001 | 1524 | 0.640 |
Why?
|
| Exons | 25 | 2014 | 2438 | 0.640 |
Why?
|
| Tooth Abnormalities | 3 | 2022 | 54 | 0.630 |
Why?
|
| Vascular Neoplasms | 2 | 2010 | 175 | 0.630 |
Why?
|
| Angiogenesis Inhibitors | 12 | 2009 | 2037 | 0.620 |
Why?
|
| Collagen Type I | 11 | 2016 | 592 | 0.610 |
Why?
|
| Pigment Epithelium of Eye | 5 | 2005 | 220 | 0.610 |
Why?
|
| Genetic Linkage | 19 | 2012 | 2419 | 0.600 |
Why?
|
| Neoplasm Proteins | 12 | 2016 | 3706 | 0.600 |
Why?
|
| Bone Marrow Cells | 6 | 2019 | 2509 | 0.590 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 8 | 2012 | 164 | 0.590 |
Why?
|
| Tooth | 1 | 2018 | 204 | 0.580 |
Why?
|
| Cloning, Molecular | 38 | 2003 | 4320 | 0.580 |
Why?
|
| Lamin Type A | 2 | 2015 | 190 | 0.580 |
Why?
|
| Stress, Mechanical | 5 | 2014 | 1684 | 0.570 |
Why?
|
| Endothelial Growth Factors | 6 | 2002 | 693 | 0.570 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 2016 | 26 | 0.570 |
Why?
|
| Chondrogenesis | 8 | 2016 | 247 | 0.560 |
Why?
|
| Stifle | 2 | 2015 | 28 | 0.550 |
Why?
|
| Chick Embryo | 47 | 2012 | 983 | 0.550 |
Why?
|
| Mice, Knockout | 31 | 2021 | 14563 | 0.550 |
Why?
|
| Alternative Splicing | 9 | 2008 | 1117 | 0.540 |
Why?
|
| Choroid | 3 | 2007 | 322 | 0.540 |
Why?
|
| Cilia | 3 | 2010 | 464 | 0.530 |
Why?
|
| Achondroplasia | 2 | 2014 | 26 | 0.530 |
Why?
|
| Mandibular Diseases | 1 | 2016 | 118 | 0.530 |
Why?
|
| Endothelium | 5 | 2017 | 777 | 0.530 |
Why?
|
| Eye Abnormalities | 6 | 2005 | 246 | 0.520 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 5 | 2013 | 664 | 0.520 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2016 | 349 | 0.520 |
Why?
|
| Chickens | 31 | 2003 | 864 | 0.510 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2014 | 5 | 0.510 |
Why?
|
| Lymphokines | 5 | 2002 | 948 | 0.510 |
Why?
|
| Cleidocranial Dysplasia | 5 | 1997 | 19 | 0.500 |
Why?
|
| Bone Diseases, Developmental | 3 | 2016 | 130 | 0.500 |
Why?
|
| Receptor, TIE-2 | 4 | 2016 | 177 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2012 | 3622 | 0.500 |
Why?
|
| Endothelium, Vascular | 13 | 2010 | 4459 | 0.490 |
Why?
|
| Cell Lineage | 7 | 2017 | 2506 | 0.490 |
Why?
|
| Activin Receptors, Type I | 3 | 2015 | 142 | 0.490 |
Why?
|
| Osteonecrosis | 1 | 2016 | 227 | 0.490 |
Why?
|
| Receptors, Cell Surface | 11 | 2019 | 2865 | 0.480 |
Why?
|
| Homeostasis | 7 | 2016 | 3337 | 0.480 |
Why?
|
| Adaptor Proteins, Signal Transducing | 10 | 2021 | 2916 | 0.480 |
Why?
|
| Osteolysis, Essential | 1 | 2014 | 30 | 0.480 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 105 | 0.480 |
Why?
|
| DNA | 44 | 2012 | 7295 | 0.470 |
Why?
|
| Blood Vessels | 4 | 2011 | 1124 | 0.470 |
Why?
|
| Mutation | 41 | 2022 | 29777 | 0.470 |
Why?
|
| Skin | 18 | 2015 | 4372 | 0.460 |
Why?
|
| beta Catenin | 5 | 2022 | 1060 | 0.460 |
Why?
|
| Fracture Healing | 1 | 2016 | 427 | 0.460 |
Why?
|
| Databases, Protein | 2 | 2015 | 383 | 0.460 |
Why?
|
| Transforming Growth Factor beta3 | 2 | 2015 | 44 | 0.450 |
Why?
|
| Biochemistry | 1 | 2014 | 113 | 0.450 |
Why?
|
| Retinal Vessels | 3 | 2016 | 772 | 0.450 |
Why?
|
| NFATC Transcription Factors | 4 | 2012 | 381 | 0.450 |
Why?
|
| Collagen Type VIII | 4 | 2009 | 15 | 0.450 |
Why?
|
| Embryo, Mammalian | 14 | 2012 | 1702 | 0.440 |
Why?
|
| Extracellular Space | 1 | 2015 | 595 | 0.440 |
Why?
|
| Morphogenesis | 8 | 2019 | 751 | 0.440 |
Why?
|
| Mice, Mutant Strains | 15 | 2014 | 1862 | 0.440 |
Why?
|
| Exostoses | 2 | 2022 | 30 | 0.430 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 338 | 0.420 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 853 | 0.420 |
Why?
|
| Proteins | 15 | 2015 | 6098 | 0.420 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2013 | 186 | 0.420 |
Why?
|
| Hyalin | 2 | 2014 | 37 | 0.420 |
Why?
|
| Osteomyelitis | 1 | 2016 | 402 | 0.420 |
Why?
|
| Hedgehog Proteins | 6 | 2015 | 784 | 0.420 |
Why?
|
| Heparitin Sulfate | 5 | 2009 | 225 | 0.410 |
Why?
|
| Contig Mapping | 3 | 2001 | 54 | 0.400 |
Why?
|
| Bone Morphogenetic Protein 4 | 3 | 2022 | 162 | 0.400 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2012 | 198 | 0.400 |
Why?
|
| Integrins | 3 | 2013 | 846 | 0.390 |
Why?
|
| In Situ Hybridization | 14 | 2009 | 1952 | 0.390 |
Why?
|
| Vision, Ocular | 2 | 2005 | 457 | 0.390 |
Why?
|
| Acetyltransferases | 3 | 2021 | 234 | 0.390 |
Why?
|
| Cells, Cultured | 45 | 2017 | 19232 | 0.390 |
Why?
|
| Osteocytes | 2 | 2021 | 195 | 0.390 |
Why?
|
| Science | 1 | 2014 | 239 | 0.390 |
Why?
|
| Bone Diseases | 3 | 2019 | 416 | 0.390 |
Why?
|
| Orofaciodigital Syndromes | 2 | 2021 | 23 | 0.380 |
Why?
|
| Body Patterning | 3 | 2007 | 629 | 0.380 |
Why?
|
| Introns | 9 | 2002 | 991 | 0.380 |
Why?
|
| Gene Expression | 21 | 2012 | 7793 | 0.380 |
Why?
|
| Extracellular Matrix Proteins | 8 | 2021 | 850 | 0.380 |
Why?
|
| Malaria | 1 | 2020 | 1239 | 0.380 |
Why?
|
| Peer Review, Research | 1 | 2014 | 329 | 0.380 |
Why?
|
| Retina | 6 | 2016 | 2612 | 0.370 |
Why?
|
| Metalloendopeptidases | 6 | 1997 | 396 | 0.370 |
Why?
|
| Humans | 203 | 2022 | 743811 | 0.370 |
Why?
|
| Microfilament Proteins | 6 | 2016 | 1152 | 0.370 |
Why?
|
| Fascia | 2 | 2008 | 135 | 0.360 |
Why?
|
| Data Mining | 1 | 2015 | 537 | 0.360 |
Why?
|
| Tissue Engineering | 4 | 2019 | 1880 | 0.360 |
Why?
|
| Dwarfism | 4 | 2022 | 145 | 0.350 |
Why?
|
| Multipotent Stem Cells | 1 | 2010 | 186 | 0.350 |
Why?
|
| Collagen Type IX | 4 | 2006 | 20 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 29 | 2021 | 21824 | 0.340 |
Why?
|
| Genes, Dominant | 9 | 2004 | 880 | 0.340 |
Why?
|
| Stem Cells | 8 | 2019 | 3566 | 0.340 |
Why?
|
| Collagen Type IV | 4 | 2013 | 140 | 0.330 |
Why?
|
| Iris | 4 | 2005 | 239 | 0.330 |
Why?
|
| Influenza in Birds | 1 | 2009 | 75 | 0.330 |
Why?
|
| RANK Ligand | 2 | 2009 | 325 | 0.330 |
Why?
|
| Neural Crest | 4 | 2017 | 275 | 0.330 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2009 | 215 | 0.330 |
Why?
|
| Collagen Type VI | 1 | 2008 | 26 | 0.320 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 690 | 0.320 |
Why?
|
| DNA, Complementary | 13 | 2004 | 2050 | 0.320 |
Why?
|
| Skull | 7 | 2016 | 812 | 0.320 |
Why?
|
| Pedigree | 25 | 2020 | 4643 | 0.320 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 140 | 0.320 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2009 | 113 | 0.310 |
Why?
|
| Protein Structure, Tertiary | 14 | 2010 | 3847 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 22 | 2009 | 6170 | 0.310 |
Why?
|
| Famous Persons | 3 | 1998 | 108 | 0.300 |
Why?
|
| Homeodomain Proteins | 5 | 2012 | 2419 | 0.300 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2008 | 133 | 0.300 |
Why?
|
| Norway | 11 | 1998 | 448 | 0.300 |
Why?
|
| LDL-Receptor Related Proteins | 2 | 2007 | 115 | 0.300 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2009 | 288 | 0.300 |
Why?
|
| Connective Tissue Diseases | 3 | 2007 | 264 | 0.290 |
Why?
|
| Trans-Activators | 4 | 2005 | 2927 | 0.290 |
Why?
|
| Periosteum | 5 | 2012 | 138 | 0.290 |
Why?
|
| RNA, Messenger | 37 | 2015 | 13028 | 0.290 |
Why?
|
| Arthritis, Gouty | 1 | 2007 | 28 | 0.290 |
Why?
|
| Diskectomy | 1 | 2009 | 206 | 0.290 |
Why?
|
| Craniofacial Abnormalities | 4 | 2020 | 315 | 0.290 |
Why?
|
| Embryonic and Fetal Development | 7 | 1999 | 438 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2001 | 367 | 0.290 |
Why?
|
| Syndactyly | 3 | 2014 | 72 | 0.290 |
Why?
|
| Genetic Markers | 8 | 2007 | 2634 | 0.290 |
Why?
|
| Keloid | 2 | 2004 | 50 | 0.290 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2007 | 193 | 0.280 |
Why?
|
| Borrelia burgdorferi Group | 2 | 1996 | 97 | 0.270 |
Why?
|
| Sirolimus | 2 | 2015 | 1565 | 0.270 |
Why?
|
| Wound Healing | 2 | 2016 | 2776 | 0.270 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2015 | 505 | 0.270 |
Why?
|
| Hair Follicle | 1 | 2008 | 209 | 0.270 |
Why?
|
| Chondrocalcinosis | 1 | 2007 | 79 | 0.270 |
Why?
|
| Scattering, Radiation | 2 | 2007 | 497 | 0.260 |
Why?
|
| Head and Neck Neoplasms | 2 | 2010 | 2736 | 0.260 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 735 | 0.260 |
Why?
|
| Angiopoietins | 1 | 2005 | 80 | 0.260 |
Why?
|
| Phosphorylation | 7 | 2015 | 8436 | 0.260 |
Why?
|
| Maxilla | 3 | 2021 | 441 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2004 | 326 | 0.250 |
Why?
|
| Disease Outbreaks | 2 | 2009 | 1771 | 0.250 |
Why?
|
| Cathepsins | 3 | 2002 | 238 | 0.250 |
Why?
|
| Fibroblasts | 15 | 2016 | 4162 | 0.250 |
Why?
|
| Sequence Homology, Amino Acid | 16 | 2003 | 2839 | 0.240 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 320 | 0.240 |
Why?
|
| Anterior Eye Segment | 1 | 2005 | 152 | 0.240 |
Why?
|
| Matrix Metalloproteinase 13 | 6 | 2012 | 103 | 0.240 |
Why?
|
| Multigene Family | 8 | 2002 | 1101 | 0.240 |
Why?
|
| Transcription, Genetic | 15 | 2008 | 7719 | 0.240 |
Why?
|
| Fibronectins | 6 | 2016 | 726 | 0.240 |
Why?
|
| Lens, Crystalline | 3 | 2003 | 388 | 0.240 |
Why?
|
| Bruch Membrane | 4 | 2007 | 64 | 0.240 |
Why?
|
| Bone Resorption | 2 | 2012 | 722 | 0.240 |
Why?
|
| Hyperuricemia | 1 | 2007 | 210 | 0.240 |
Why?
|
| Immunohistochemistry | 17 | 2012 | 11360 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2004 | 322 | 0.240 |
Why?
|
| Laminin | 5 | 2013 | 419 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2016 | 1678 | 0.240 |
Why?
|
| Protein Isoforms | 6 | 2013 | 1729 | 0.240 |
Why?
|
| DNA Primers | 12 | 2012 | 2891 | 0.240 |
Why?
|
| Physician's Role | 3 | 1997 | 942 | 0.230 |
Why?
|
| Choroidal Neovascularization | 1 | 2007 | 343 | 0.230 |
Why?
|
| Receptors, Mitogen | 4 | 2007 | 62 | 0.230 |
Why?
|
| Fluorescent Antibody Technique | 9 | 2010 | 2503 | 0.220 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2003 | 126 | 0.220 |
Why?
|
| Iris Diseases | 1 | 2003 | 40 | 0.220 |
Why?
|
| Cathepsin B | 2 | 2002 | 82 | 0.220 |
Why?
|
| Gene Expression Regulation | 11 | 2017 | 12066 | 0.220 |
Why?
|
| Bone Marrow | 4 | 2015 | 2951 | 0.220 |
Why?
|
| Odontoma | 1 | 2022 | 5 | 0.220 |
Why?
|
| Blotting, Northern | 12 | 2003 | 1581 | 0.220 |
Why?
|
| Hospitals, Municipal | 2 | 1993 | 19 | 0.220 |
Why?
|
| Tooth, Supernumerary | 1 | 2022 | 8 | 0.220 |
Why?
|
| Amelogenesis Imperfecta | 1 | 2022 | 4 | 0.220 |
Why?
|
| Restriction Mapping | 11 | 1998 | 878 | 0.210 |
Why?
|
| Birds | 2 | 2009 | 163 | 0.210 |
Why?
|
| Cell Division | 14 | 2009 | 4568 | 0.210 |
Why?
|
| Endocytosis | 1 | 2007 | 985 | 0.210 |
Why?
|
| Incisor | 2 | 2014 | 170 | 0.210 |
Why?
|
| Exfoliation Syndrome | 1 | 2003 | 110 | 0.210 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 627 | 0.210 |
Why?
|
| Adipose Tissue | 2 | 2015 | 3280 | 0.210 |
Why?
|
| Glomerular Mesangium | 3 | 2009 | 108 | 0.210 |
Why?
|
| Membrane Proteins | 9 | 2007 | 7880 | 0.210 |
Why?
|
| Microscopy, Electron | 33 | 2002 | 2646 | 0.210 |
Why?
|
| Collagen Type XI | 4 | 2006 | 20 | 0.210 |
Why?
|
| Molecular Weight | 23 | 2000 | 2253 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2004 | 3024 | 0.200 |
Why?
|
| Myeloid Cells | 1 | 2007 | 808 | 0.200 |
Why?
|
| Aging | 5 | 2015 | 8655 | 0.200 |
Why?
|
| Tibia | 6 | 2021 | 1077 | 0.200 |
Why?
|
| Voluntary Health Agencies | 1 | 2001 | 39 | 0.200 |
Why?
|
| Proteomics | 1 | 2015 | 3639 | 0.200 |
Why?
|
| Skin Neoplasms | 7 | 2010 | 5691 | 0.200 |
Why?
|
| Nails, Malformed | 1 | 2001 | 32 | 0.200 |
Why?
|
| Protease Inhibitors | 5 | 1997 | 792 | 0.200 |
Why?
|
| Political Systems | 2 | 1998 | 23 | 0.200 |
Why?
|
| Muridae | 4 | 1994 | 61 | 0.200 |
Why?
|
| Radiography | 9 | 2014 | 7010 | 0.200 |
Why?
|
| Male | 79 | 2022 | 349776 | 0.190 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 3769 | 0.190 |
Why?
|
| Bacterial Toxins | 1 | 2007 | 931 | 0.190 |
Why?
|
| Aphakia | 1 | 2001 | 24 | 0.190 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 1172 | 0.190 |
Why?
|
| Macromolecular Substances | 18 | 1997 | 1454 | 0.190 |
Why?
|
| Down-Regulation | 1 | 2008 | 3000 | 0.190 |
Why?
|
| Hypertelorism | 1 | 2020 | 32 | 0.190 |
Why?
|
| Gene Deletion | 4 | 2017 | 2749 | 0.190 |
Why?
|
| Inflammation | 6 | 2014 | 10629 | 0.190 |
Why?
|
| Protein Biosynthesis | 14 | 1995 | 2123 | 0.190 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2001 | 50 | 0.190 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 2007 | 1660 | 0.190 |
Why?
|
| Syndrome | 12 | 2009 | 3249 | 0.190 |
Why?
|
| Osteogenesis Imperfecta | 2 | 2021 | 83 | 0.190 |
Why?
|
| Phenotype | 15 | 2022 | 16361 | 0.190 |
Why?
|
| Light | 1 | 2007 | 1365 | 0.190 |
Why?
|
| Ectromelia | 1 | 2020 | 31 | 0.190 |
Why?
|
| Osteoporosis | 5 | 2015 | 1577 | 0.190 |
Why?
|
| Disease Models, Animal | 17 | 2021 | 18027 | 0.190 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1120 | 0.190 |
Why?
|
| Ciliary Body | 4 | 2005 | 173 | 0.180 |
Why?
|
| Cornea | 11 | 2005 | 1521 | 0.180 |
Why?
|
| Glomus Tumor | 4 | 2002 | 66 | 0.180 |
Why?
|
| Embryonic Development | 2 | 2012 | 710 | 0.180 |
Why?
|
| Alkaline Phosphatase | 4 | 2012 | 866 | 0.180 |
Why?
|
| Proline | 9 | 2007 | 457 | 0.180 |
Why?
|
| Sequence Homology, Nucleic Acid | 10 | 1992 | 1085 | 0.180 |
Why?
|
| Alleles | 13 | 2014 | 6934 | 0.180 |
Why?
|
| Female | 77 | 2021 | 380020 | 0.180 |
Why?
|
| Sequence Alignment | 11 | 2004 | 2256 | 0.180 |
Why?
|
| Codon, Nonsense | 1 | 2001 | 281 | 0.180 |
Why?
|
| Lyme Disease | 2 | 1996 | 621 | 0.180 |
Why?
|
| Relief Work | 1 | 2001 | 137 | 0.180 |
Why?
|
| Knee Joint | 5 | 2017 | 1680 | 0.180 |
Why?
|
| Anion Transport Proteins | 1 | 2020 | 142 | 0.180 |
Why?
|
| Histocytochemistry | 5 | 2007 | 719 | 0.180 |
Why?
|
| Molecular Biology | 3 | 1996 | 595 | 0.170 |
Why?
|
| Glycoproteins | 6 | 2016 | 2266 | 0.170 |
Why?
|
| Antigens, CD | 2 | 2016 | 4026 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2001 | 403 | 0.170 |
Why?
|
| Apoptosis | 12 | 2012 | 9718 | 0.170 |
Why?
|
| Animals, Newborn | 9 | 2016 | 2725 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3255 | 0.170 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2020 | 81 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 1364 | 0.170 |
Why?
|
| Kidney | 5 | 2009 | 7185 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2005 | 1222 | 0.170 |
Why?
|
| Transforming Growth Factor beta2 | 2 | 2010 | 75 | 0.170 |
Why?
|
| Antibodies | 9 | 2017 | 2459 | 0.170 |
Why?
|
| Antiporters | 1 | 2020 | 277 | 0.170 |
Why?
|
| Up-Regulation | 6 | 2015 | 4221 | 0.170 |
Why?
|
| Lymphangiogenesis | 2 | 2014 | 173 | 0.170 |
Why?
|
| Glycosaminoglycans | 6 | 2013 | 624 | 0.170 |
Why?
|
| Species Specificity | 10 | 2012 | 2480 | 0.160 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 1677 | 0.160 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2009 | 644 | 0.160 |
Why?
|
| Mandible | 3 | 2021 | 718 | 0.160 |
Why?
|
| Cleft Palate | 2 | 2021 | 560 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2001 | 473 | 0.160 |
Why?
|
| Human Rights | 1 | 2001 | 307 | 0.160 |
Why?
|
| Cell Survival | 4 | 2005 | 5881 | 0.160 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 2 | 1997 | 68 | 0.160 |
Why?
|
| Cell Adhesion | 5 | 2009 | 3144 | 0.160 |
Why?
|
| Cell Movement | 6 | 2010 | 5216 | 0.160 |
Why?
|
| Paranoid Behavior | 1 | 1997 | 5 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1999 | 374 | 0.160 |
Why?
|
| Dental Research | 1 | 2018 | 58 | 0.160 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 1998 | 36 | 0.160 |
Why?
|
| Cell Line | 13 | 2015 | 15993 | 0.160 |
Why?
|
| Cell Count | 4 | 2015 | 1855 | 0.160 |
Why?
|
| Regeneration | 4 | 2016 | 1486 | 0.150 |
Why?
|
| Plasmids | 6 | 2008 | 2308 | 0.150 |
Why?
|
| Mice, Inbred Strains | 5 | 2012 | 1826 | 0.150 |
Why?
|
| Chromosomes | 3 | 2012 | 596 | 0.150 |
Why?
|
| Protein Sorting Signals | 2 | 1997 | 281 | 0.150 |
Why?
|
| Models, Biological | 11 | 2015 | 9582 | 0.150 |
Why?
|
| Eye | 5 | 2005 | 727 | 0.150 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2566 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 13 | 2000 | 1800 | 0.150 |
Why?
|
| Immunoblotting | 6 | 2010 | 1683 | 0.150 |
Why?
|
| Muscle, Skeletal | 2 | 2007 | 4925 | 0.140 |
Why?
|
| Child, Hospitalized | 1 | 1998 | 174 | 0.140 |
Why?
|
| Canaries | 1 | 1996 | 6 | 0.140 |
Why?
|
| DNA, Bacterial | 5 | 2001 | 1463 | 0.140 |
Why?
|
| Students, Dental | 1 | 2018 | 159 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 1997 | 460 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 1994 | 230 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 1 | 5 | 2001 | 657 | 0.140 |
Why?
|
| Corneal Transplantation | 1 | 2020 | 384 | 0.140 |
Why?
|
| History, 20th Century | 5 | 2014 | 2736 | 0.140 |
Why?
|
| Cell Proliferation | 7 | 2016 | 10477 | 0.140 |
Why?
|
| Liberia | 1 | 2016 | 167 | 0.140 |
Why?
|
| Education, Dental | 1 | 2018 | 215 | 0.140 |
Why?
|
| Veins | 3 | 1999 | 770 | 0.140 |
Why?
|
| Sierra Leone | 1 | 2016 | 166 | 0.140 |
Why?
|
| Apatites | 1 | 2015 | 19 | 0.140 |
Why?
|
| Goats | 6 | 2013 | 171 | 0.130 |
Why?
|
| Genes, Reporter | 4 | 2015 | 1545 | 0.130 |
Why?
|
| Medicine in Literature | 1 | 1995 | 31 | 0.130 |
Why?
|
| Haemophilus ducreyi | 3 | 2001 | 4 | 0.130 |
Why?
|
| Jaw | 2 | 2014 | 96 | 0.130 |
Why?
|
| Polydactyly | 1 | 1996 | 57 | 0.130 |
Why?
|
| Ki-67 Antigen | 2 | 2009 | 644 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2005 | 1503 | 0.130 |
Why?
|
| Japan | 2 | 2014 | 1360 | 0.130 |
Why?
|
| Cleft Lip | 1 | 2021 | 478 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1996 | 794 | 0.130 |
Why?
|
| Emigration and Immigration | 1 | 1998 | 402 | 0.130 |
Why?
|
| Fluocinolone Acetonide | 1 | 2015 | 36 | 0.130 |
Why?
|
| Tropical Medicine | 1 | 1995 | 49 | 0.130 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2015 | 27 | 0.130 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2015 | 247 | 0.130 |
Why?
|
| Publishing | 1 | 2002 | 833 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2014 | 2453 | 0.130 |
Why?
|
| Scoliosis | 1 | 2022 | 725 | 0.130 |
Why?
|
| Refugees | 2 | 2001 | 511 | 0.130 |
Why?
|
| Toes | 1 | 1996 | 206 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2008 | 3772 | 0.130 |
Why?
|
| DNA Mutational Analysis | 7 | 2003 | 4183 | 0.130 |
Why?
|
| Genes, Homeobox | 1 | 1996 | 286 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 4463 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 770 | 0.130 |
Why?
|
| Tissue Distribution | 7 | 2003 | 2327 | 0.130 |
Why?
|
| Transglutaminases | 2 | 2010 | 194 | 0.120 |
Why?
|
| Health Services Administration | 1 | 1995 | 64 | 0.120 |
Why?
|
| Growth Disorders | 2 | 2015 | 645 | 0.120 |
Why?
|
| Trypsin | 11 | 1992 | 511 | 0.120 |
Why?
|
| Binding Sites | 6 | 2013 | 6111 | 0.120 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 9 | 1997 | 34 | 0.120 |
Why?
|
| Orthodontic Wires | 1 | 2014 | 22 | 0.120 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2015 | 471 | 0.120 |
Why?
|
| Infant | 11 | 2020 | 35122 | 0.120 |
Why?
|
| Collagenases | 4 | 2006 | 228 | 0.120 |
Why?
|
| Blotting, Western | 6 | 2008 | 5179 | 0.120 |
Why?
|
| Acid Phosphatase | 1 | 2014 | 142 | 0.120 |
Why?
|
| Heterozygote | 7 | 2006 | 2803 | 0.120 |
Why?
|
| Crosses, Genetic | 4 | 2012 | 791 | 0.120 |
Why?
|
| Lod Score | 5 | 2001 | 613 | 0.120 |
Why?
|
| Rhodopsin | 2 | 2005 | 203 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 1995 | 351 | 0.120 |
Why?
|
| Palate, Hard | 2 | 2012 | 57 | 0.120 |
Why?
|
| Osteogenesis, Distraction | 1 | 2016 | 218 | 0.120 |
Why?
|
| Disease Reservoirs | 2 | 2009 | 131 | 0.120 |
Why?
|
| Health Services Needs and Demand | 2 | 1993 | 1411 | 0.120 |
Why?
|
| Calciphylaxis | 1 | 2015 | 124 | 0.120 |
Why?
|
| Embryo, Nonmammalian | 3 | 2017 | 895 | 0.110 |
Why?
|
| Retinal Neovascularization | 1 | 2016 | 244 | 0.110 |
Why?
|
| Attitude | 1 | 2018 | 775 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2003 | 838 | 0.110 |
Why?
|
| Urinary Bladder Diseases | 1 | 1994 | 166 | 0.110 |
Why?
|
| Macular Degeneration | 3 | 2007 | 981 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1656 | 0.110 |
Why?
|
| Epitopes | 3 | 1993 | 2570 | 0.110 |
Why?
|
| Capillary Permeability | 3 | 2007 | 798 | 0.110 |
Why?
|
| Molar | 1 | 2014 | 148 | 0.110 |
Why?
|
| Cystitis | 1 | 1993 | 93 | 0.110 |
Why?
|
| Muscles | 2 | 1997 | 1613 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1994 | 287 | 0.110 |
Why?
|
| Diverticulum | 1 | 1994 | 134 | 0.110 |
Why?
|
| Electroretinography | 2 | 2005 | 509 | 0.110 |
Why?
|
| Fingers | 1 | 1996 | 513 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2014 | 4422 | 0.110 |
Why?
|
| Physicians | 3 | 1998 | 4569 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2012 | 10 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1709 | 0.110 |
Why?
|
| Collagen Type X | 1 | 2012 | 16 | 0.110 |
Why?
|
| Hospitals, District | 1 | 1993 | 106 | 0.110 |
Why?
|
| Tissue Scaffolds | 2 | 2010 | 956 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 4 | 2022 | 2006 | 0.110 |
Why?
|
| RNA Interference | 2 | 2012 | 2890 | 0.110 |
Why?
|
| Co-Repressor Proteins | 2 | 2004 | 194 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2014 | 243 | 0.110 |
Why?
|
| Sternum | 2 | 1993 | 177 | 0.110 |
Why?
|
| Transfection | 7 | 2008 | 5892 | 0.110 |
Why?
|
| Bone Density | 5 | 2021 | 3460 | 0.110 |
Why?
|
| Environmental Pollution | 1 | 1993 | 118 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 104 | 0.110 |
Why?
|
| Cell Enlargement | 1 | 2012 | 61 | 0.110 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1993 | 261 | 0.110 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 354 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2012 | 67 | 0.100 |
Why?
|
| Xenopus Proteins | 1 | 1995 | 432 | 0.100 |
Why?
|
| Femur | 3 | 2021 | 1296 | 0.100 |
Why?
|
| Colony-Forming Units Assay | 1 | 2012 | 355 | 0.100 |
Why?
|
| Paracrine Communication | 1 | 2013 | 278 | 0.100 |
Why?
|
| Lectins, C-Type | 2 | 2014 | 589 | 0.100 |
Why?
|
| Mutagenesis | 4 | 2012 | 1263 | 0.100 |
Why?
|
| Limb Buds | 1 | 2012 | 77 | 0.100 |
Why?
|
| Health Surveys | 2 | 1993 | 4036 | 0.100 |
Why?
|
| Hindlimb | 3 | 2007 | 503 | 0.100 |
Why?
|
| Recombinant Proteins | 9 | 2009 | 6620 | 0.100 |
Why?
|
| Limb Deformities, Congenital | 1 | 1993 | 136 | 0.100 |
Why?
|
| Muscular Dystrophies | 2 | 2008 | 393 | 0.100 |
Why?
|
| Protein Structure, Secondary | 7 | 1998 | 1245 | 0.100 |
Why?
|
| Haplotypes | 7 | 2004 | 2779 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2012 | 171 | 0.100 |
Why?
|
| Cell Transformation, Viral | 1 | 1993 | 566 | 0.100 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1997 | 623 | 0.100 |
Why?
|
| Health Status | 2 | 1998 | 4031 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2002 | 1429 | 0.100 |
Why?
|
| Russia | 3 | 1997 | 408 | 0.100 |
Why?
|
| Coloring Agents | 1 | 2014 | 565 | 0.100 |
Why?
|
| Violence | 1 | 1997 | 909 | 0.100 |
Why?
|
| Retinal Degeneration | 3 | 2005 | 415 | 0.100 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 906 | 0.100 |
Why?
|
| Cadherins | 1 | 2016 | 907 | 0.100 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 2 | 2008 | 64 | 0.100 |
Why?
|
| Biopolymers | 1 | 2012 | 189 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 7 | 2008 | 5867 | 0.100 |
Why?
|
| Protein Binding | 11 | 2013 | 9377 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 567 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1374 | 0.100 |
Why?
|
| Codon | 3 | 2003 | 611 | 0.100 |
Why?
|
| Wnt Proteins | 3 | 2022 | 721 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1342 | 0.100 |
Why?
|
| Infant, Newborn | 7 | 2010 | 25609 | 0.090 |
Why?
|
| Alopecia | 1 | 2015 | 382 | 0.090 |
Why?
|
| Neurogenesis | 1 | 2017 | 838 | 0.090 |
Why?
|
| Receptors, Growth Factor | 2 | 2002 | 334 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2015 | 981 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 2012 | 454 | 0.090 |
Why?
|
| Stromal Cells | 4 | 2010 | 1356 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 9 | 1991 | 1374 | 0.090 |
Why?
|
| Inheritance Patterns | 1 | 2012 | 339 | 0.090 |
Why?
|
| Rats | 17 | 2007 | 24250 | 0.090 |
Why?
|
| Antineoplastic Agents | 4 | 2002 | 13691 | 0.090 |
Why?
|
| Kidney Glomerulus | 1 | 1993 | 697 | 0.090 |
Why?
|
| Peptides | 11 | 1997 | 4406 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 434 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2014 | 571 | 0.090 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 851 | 0.090 |
Why?
|
| Joints | 2 | 2006 | 326 | 0.090 |
Why?
|
| Biological Transport | 3 | 2009 | 2119 | 0.090 |
Why?
|
| Fluorescein Angiography | 2 | 2005 | 940 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2017 | 5973 | 0.090 |
Why?
|
| RNA | 5 | 2009 | 2748 | 0.090 |
Why?
|
| Protein Conformation | 13 | 2020 | 4009 | 0.090 |
Why?
|
| Models, Animal | 4 | 2013 | 2172 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2017 | 3912 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 7 | 2003 | 6311 | 0.090 |
Why?
|
| Gene Fusion | 1 | 2012 | 371 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2014 | 4033 | 0.090 |
Why?
|
| Carrier Proteins | 4 | 2001 | 5021 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 7 | 2009 | 9272 | 0.090 |
Why?
|
| Down Syndrome | 3 | 2008 | 880 | 0.090 |
Why?
|
| Nasal Cartilages | 1 | 2009 | 14 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 5 | 1994 | 798 | 0.090 |
Why?
|
| Polymorphism, Genetic | 10 | 2004 | 4326 | 0.090 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2009 | 46 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2012 | 492 | 0.090 |
Why?
|
| Bacteremia | 1 | 1996 | 963 | 0.090 |
Why?
|
| Socioeconomic Factors | 3 | 1998 | 7784 | 0.080 |
Why?
|
| Animals, Wild | 1 | 2009 | 88 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2014 | 1728 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2583 | 0.080 |
Why?
|
| Liver | 7 | 2014 | 7479 | 0.080 |
Why?
|
| Microscopy | 4 | 2008 | 896 | 0.080 |
Why?
|
| Mice, Inbred C3H | 4 | 1997 | 964 | 0.080 |
Why?
|
| Protein Precursors | 8 | 1981 | 1154 | 0.080 |
Why?
|
| Organ Specificity | 6 | 2004 | 2008 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2014 | 541 | 0.080 |
Why?
|
| Communicable Disease Control | 1 | 1995 | 856 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1997 | 2232 | 0.080 |
Why?
|
| Integrin beta Chains | 1 | 2008 | 121 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2008 | 118 | 0.080 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 216 | 0.080 |
Why?
|
| Endopeptidases | 3 | 2000 | 772 | 0.080 |
Why?
|
| Keratin-14 | 1 | 2008 | 57 | 0.080 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2008 | 154 | 0.080 |
Why?
|
| Role | 1 | 1988 | 175 | 0.080 |
Why?
|
| Genetic Heterogeneity | 2 | 2002 | 733 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1995 | 1434 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9648 | 0.080 |
Why?
|
| Osteoprotegerin | 1 | 2008 | 176 | 0.080 |
Why?
|
| Bromodeoxyuridine | 1 | 2008 | 322 | 0.080 |
Why?
|
| Russia (Pre-1917) | 2 | 1998 | 4 | 0.080 |
Why?
|
| Morbidity | 1 | 1993 | 1768 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1532 | 0.080 |
Why?
|
| Angiopoietin-1 | 1 | 2008 | 114 | 0.080 |
Why?
|
| Lac Operon | 1 | 2008 | 239 | 0.080 |
Why?
|
| Ligands | 4 | 2005 | 3281 | 0.080 |
Why?
|
| Homozygote | 5 | 2007 | 1787 | 0.080 |
Why?
|
| Cathepsin L | 3 | 2002 | 74 | 0.080 |
Why?
|
| Oligopeptides | 2 | 2009 | 1188 | 0.080 |
Why?
|
| Intercellular Junctions | 1 | 2008 | 203 | 0.080 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 60 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2009 | 431 | 0.080 |
Why?
|
| Oligonucleotides | 1 | 2010 | 572 | 0.080 |
Why?
|
| Penetrance | 3 | 2004 | 381 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 2750 | 0.080 |
Why?
|
| DNA Restriction Enzymes | 6 | 1986 | 570 | 0.070 |
Why?
|
| Pichia | 1 | 2007 | 51 | 0.070 |
Why?
|
| Angiopoietin-2 | 1 | 2008 | 172 | 0.070 |
Why?
|
| Hydroxyapatites | 1 | 2007 | 74 | 0.070 |
Why?
|
| GTP-Binding Proteins | 2 | 2010 | 969 | 0.070 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 308 | 0.070 |
Why?
|
| Fluoresceins | 1 | 2007 | 235 | 0.070 |
Why?
|
| Oncogenes | 1 | 1993 | 1265 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 1998 | 133 | 0.070 |
Why?
|
| Spine | 2 | 2001 | 1144 | 0.070 |
Why?
|
| Genotype | 9 | 2012 | 12944 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 6 | 2012 | 4803 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2014 | 1640 | 0.070 |
Why?
|
| Encephalocele | 2 | 2005 | 136 | 0.070 |
Why?
|
| Abnormalities, Multiple | 4 | 2008 | 1416 | 0.070 |
Why?
|
| Gene Library | 4 | 1994 | 1074 | 0.070 |
Why?
|
| Cholelithiasis | 1 | 1988 | 414 | 0.070 |
Why?
|
| Glucuronidase | 1 | 2008 | 207 | 0.070 |
Why?
|
| Capillaries | 3 | 2005 | 773 | 0.070 |
Why?
|
| Adiposis Dolorosa | 1 | 1986 | 12 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 1996 | 2073 | 0.070 |
Why?
|
| Hydrogels | 1 | 2012 | 727 | 0.070 |
Why?
|
| Health Policy | 2 | 1997 | 2662 | 0.070 |
Why?
|
| Crystallization | 2 | 2007 | 525 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 1993 | 975 | 0.070 |
Why?
|
| Mice, Inbred DBA | 4 | 2012 | 642 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 6 | 2015 | 6380 | 0.070 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 1996 | 163 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5854 | 0.070 |
Why?
|
| Community Health Services | 1 | 1991 | 650 | 0.070 |
Why?
|
| Invertebrates | 1 | 2005 | 50 | 0.070 |
Why?
|
| Dogs | 2 | 2008 | 3911 | 0.070 |
Why?
|
| Faculty, Medical | 1 | 2014 | 1181 | 0.070 |
Why?
|
| Neurons | 3 | 2017 | 9336 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2012 | 1344 | 0.070 |
Why?
|
| Microphthalmos | 1 | 2005 | 54 | 0.070 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 2401 | 0.070 |
Why?
|
| Neoplasms, Experimental | 2 | 2004 | 1272 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 1997 | 299 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 349 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4749 | 0.060 |
Why?
|
| Oligonucleotide Probes | 3 | 1990 | 427 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2004 | 6535 | 0.060 |
Why?
|
| Protein Interaction Mapping | 1 | 2009 | 626 | 0.060 |
Why?
|
| Specialization | 1 | 1990 | 775 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 480 | 0.060 |
Why?
|
| Skull Base | 1 | 2008 | 305 | 0.060 |
Why?
|
| Point Mutation | 3 | 1996 | 1623 | 0.060 |
Why?
|
| DNA Probes | 3 | 1992 | 560 | 0.060 |
Why?
|
| Staining and Labeling | 7 | 2015 | 1098 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 489 | 0.060 |
Why?
|
| Gene Targeting | 4 | 2003 | 879 | 0.060 |
Why?
|
| Urinary Incontinence | 1 | 1989 | 496 | 0.060 |
Why?
|
| Arginine | 2 | 2007 | 943 | 0.060 |
Why?
|
| Ferritins | 5 | 1975 | 590 | 0.060 |
Why?
|
| COS Cells | 2 | 2004 | 1161 | 0.060 |
Why?
|
| Commerce | 1 | 1990 | 592 | 0.060 |
Why?
|
| Vasa Vasorum | 1 | 2004 | 26 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 3 | 2002 | 563 | 0.060 |
Why?
|
| Clavicle | 2 | 1997 | 209 | 0.060 |
Why?
|
| History, 19th Century | 2 | 1998 | 720 | 0.060 |
Why?
|
| Microvessels | 1 | 2009 | 544 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 1995 | 2211 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 4 | 2004 | 1799 | 0.060 |
Why?
|
| Hydrolysis | 3 | 2001 | 683 | 0.060 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2008 | 417 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2013 | 1253 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 644 | 0.060 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 2001 | 118 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2003 | 769 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2016 | 1946 | 0.060 |
Why?
|
| PAX9 Transcription Factor | 1 | 2003 | 13 | 0.060 |
Why?
|
| Vertebrates | 1 | 2005 | 228 | 0.060 |
Why?
|
| Extraembryonic Membranes | 1 | 1984 | 41 | 0.060 |
Why?
|
| Endothelium, Corneal | 2 | 2005 | 197 | 0.060 |
Why?
|
| Blindness | 3 | 2005 | 612 | 0.060 |
Why?
|
| Microdissection | 1 | 2004 | 152 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 6 | 1997 | 1146 | 0.060 |
Why?
|
| Histological Techniques | 1 | 2004 | 198 | 0.060 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2005 | 204 | 0.060 |
Why?
|
| Cricetinae | 3 | 2009 | 2475 | 0.060 |
Why?
|
| Child, Preschool | 9 | 2020 | 40964 | 0.060 |
Why?
|
| Molecular Structure | 2 | 2004 | 1894 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2001 | 4552 | 0.060 |
Why?
|
| Extremities | 2 | 2014 | 867 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 1996 | 535 | 0.060 |
Why?
|
| Umbilical Veins | 1 | 2004 | 433 | 0.060 |
Why?
|
| DNA, Recombinant | 2 | 1984 | 476 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2010 | 1793 | 0.060 |
Why?
|
| Uveal Diseases | 1 | 2003 | 45 | 0.060 |
Why?
|
| Poverty | 1 | 1995 | 2660 | 0.060 |
Why?
|
| Osteoarthritis, Knee | 2 | 2004 | 1222 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.060 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2003 | 29 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 464 | 0.060 |
Why?
|
| Hybrid Cells | 2 | 1994 | 441 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 319 | 0.060 |
Why?
|
| Alginates | 2 | 2001 | 252 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2003 | 194 | 0.060 |
Why?
|
| Cattle | 10 | 2000 | 3917 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2010 | 821 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 1311 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 2110 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2015 | 3680 | 0.060 |
Why?
|
| Surface Plasmon Resonance | 3 | 2010 | 274 | 0.050 |
Why?
|
| Hematologic Diseases | 1 | 2007 | 498 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14714 | 0.050 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2004 | 117 | 0.050 |
Why?
|
| Calcium | 2 | 2015 | 5755 | 0.050 |
Why?
|
| Ophthalmoscopy | 1 | 2003 | 176 | 0.050 |
Why?
|
| Time Factors | 10 | 2018 | 40038 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 4 | 1973 | 271 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 1115 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 1995 | 708 | 0.050 |
Why?
|
| Muscle Development | 2 | 1995 | 272 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 6 | 2010 | 2692 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 2938 | 0.050 |
Why?
|
| Adiposity | 1 | 2012 | 1806 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 429 | 0.050 |
Why?
|
| Disease Progression | 2 | 2017 | 13273 | 0.050 |
Why?
|
| Health Services Research | 1 | 1990 | 1836 | 0.050 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2022 | 42 | 0.050 |
Why?
|
| Thrombospondin 1 | 1 | 2004 | 250 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2008 | 878 | 0.050 |
Why?
|
| Skin Transplantation | 1 | 2008 | 1074 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 528 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1114 | 0.050 |
Why?
|
| Europe | 1 | 2009 | 3336 | 0.050 |
Why?
|
| Vascular Malformations | 1 | 2008 | 454 | 0.050 |
Why?
|
| Atrophy | 2 | 2008 | 1577 | 0.050 |
Why?
|
| Cytokines | 1 | 1997 | 7324 | 0.050 |
Why?
|
| Mortality | 1 | 1993 | 2862 | 0.050 |
Why?
|
| Embryonic Induction | 1 | 2002 | 149 | 0.050 |
Why?
|
| Glutaminase | 2 | 1973 | 35 | 0.050 |
Why?
|
| Publication Bias | 1 | 2002 | 162 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2001 | 1102 | 0.050 |
Why?
|
| Retinal Detachment | 2 | 2004 | 411 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2009 | 984 | 0.050 |
Why?
|
| Osteopetrosis | 1 | 2001 | 43 | 0.050 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2021 | 17 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2003 | 440 | 0.050 |
Why?
|
| DNA, Circular | 1 | 1982 | 97 | 0.050 |
Why?
|
| Culture Media, Conditioned | 4 | 2010 | 537 | 0.050 |
Why?
|
| Adolescent | 11 | 2020 | 85729 | 0.050 |
Why?
|
| Phosphate Transport Proteins | 1 | 2001 | 8 | 0.050 |
Why?
|
| Registries | 2 | 2008 | 8090 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 595 | 0.050 |
Why?
|
| Family Health | 2 | 2004 | 1280 | 0.050 |
Why?
|
| Gliosarcoma | 1 | 2002 | 114 | 0.050 |
Why?
|
| MSX1 Transcription Factor | 1 | 2001 | 53 | 0.050 |
Why?
|
| Child | 13 | 2020 | 77637 | 0.050 |
Why?
|
| Fibril-Associated Collagens | 1 | 2001 | 2 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 2914 | 0.050 |
Why?
|
| Kidney Cortex | 2 | 2009 | 186 | 0.050 |
Why?
|
| Patients | 1 | 2008 | 899 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2002 | 286 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2001 | 26 | 0.050 |
Why?
|
| Skin Diseases, Genetic | 1 | 2001 | 41 | 0.050 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2006 | 133 | 0.050 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 2 | 1997 | 18 | 0.050 |
Why?
|
| Escherichia coli Proteins | 2 | 1998 | 1050 | 0.050 |
Why?
|
| Sequence Tagged Sites | 1 | 2001 | 94 | 0.050 |
Why?
|
| Melanins | 1 | 2003 | 289 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5532 | 0.050 |
Why?
|
| Rabbits | 11 | 2001 | 4894 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2001 | 126 | 0.050 |
Why?
|
| Boston | 1 | 2014 | 9310 | 0.050 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2001 | 404 | 0.050 |
Why?
|
| Chromosomes, Artificial | 1 | 2000 | 3 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2002 | 195 | 0.050 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2001 | 178 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1880 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 805 | 0.050 |
Why?
|
| Matrix Metalloproteinase 14 | 2 | 1997 | 61 | 0.050 |
Why?
|
| Pericytes | 1 | 2003 | 293 | 0.050 |
Why?
|
| Ligaments | 2 | 1993 | 129 | 0.050 |
Why?
|
| Pain | 1 | 2016 | 4987 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 1993 | 3391 | 0.050 |
Why?
|
| United Nations | 1 | 2001 | 165 | 0.050 |
Why?
|
| Aorta | 2 | 2005 | 2062 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1993 | 2248 | 0.050 |
Why?
|
| Spleen | 1 | 2007 | 2359 | 0.050 |
Why?
|
| Glioma | 3 | 2001 | 3401 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 1999 | 897 | 0.050 |
Why?
|
| Kinetics | 5 | 2009 | 6476 | 0.050 |
Why?
|
| Vitamin A | 1 | 2003 | 615 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2012 | 300 | 0.050 |
Why?
|
| Humerus | 1 | 2002 | 266 | 0.050 |
Why?
|
| Procollagen-Proline Dioxygenase | 4 | 1975 | 86 | 0.050 |
Why?
|
| Paired Box Transcription Factors | 1 | 2001 | 214 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 3645 | 0.050 |
Why?
|
| Founder Effect | 1 | 2020 | 189 | 0.040 |
Why?
|
| Lymph Nodes | 3 | 2012 | 3476 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 2002 | 345 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2001 | 209 | 0.040 |
Why?
|
| Peptide Mapping | 2 | 1991 | 263 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2001 | 417 | 0.040 |
Why?
|
| Endosomes | 1 | 2002 | 518 | 0.040 |
Why?
|
| Forecasting | 1 | 1988 | 2950 | 0.040 |
Why?
|
| Sulfates | 3 | 1997 | 390 | 0.040 |
Why?
|
| Resins, Synthetic | 1 | 1979 | 28 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 4777 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2001 | 477 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1999 | 352 | 0.040 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 1998 | 12 | 0.040 |
Why?
|
| Lysosomes | 2 | 2002 | 893 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 1958 | 0.040 |
Why?
|
| Hearing | 1 | 2003 | 482 | 0.040 |
Why?
|
| Adult | 15 | 2020 | 213889 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2000 | 1986 | 0.040 |
Why?
|
| Pepsin A | 4 | 1986 | 71 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 2 | 2010 | 250 | 0.040 |
Why?
|
| Isomerism | 2 | 1995 | 201 | 0.040 |
Why?
|
| Peptide Hydrolases | 2 | 2000 | 633 | 0.040 |
Why?
|
| Heparin | 2 | 2003 | 1637 | 0.040 |
Why?
|
| Cerebellum | 2 | 2004 | 1487 | 0.040 |
Why?
|
| Alveolar Process | 1 | 1999 | 286 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2005 | 1055 | 0.040 |
Why?
|
| Aortic Diseases | 1 | 2004 | 743 | 0.040 |
Why?
|
| Karyotyping | 2 | 1991 | 1243 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 1084 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 2241 | 0.040 |
Why?
|
| Vitamin D | 2 | 2009 | 3222 | 0.040 |
Why?
|
| Polyvinyls | 1 | 1979 | 157 | 0.040 |
Why?
|
| Pseudohypoparathyroidism | 1 | 1998 | 90 | 0.040 |
Why?
|
| Amino Acids | 9 | 1985 | 1733 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1994 | 2649 | 0.040 |
Why?
|
| Electrons | 3 | 1964 | 268 | 0.040 |
Why?
|
| Editorial Policies | 1 | 2002 | 451 | 0.040 |
Why?
|
| Vitreous Body | 2 | 1993 | 389 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 561 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 901 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 1991 | 1574 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2009 | 1480 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 3 | 1998 | 264 | 0.040 |
Why?
|
| Allantois | 1 | 1997 | 33 | 0.040 |
Why?
|
| Age Factors | 2 | 2021 | 18355 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 3874 | 0.040 |
Why?
|
| Brain | 2 | 2002 | 26345 | 0.040 |
Why?
|
| RNA Splicing | 2 | 1999 | 907 | 0.040 |
Why?
|
| Escherichia coli | 7 | 2001 | 4216 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2001 | 581 | 0.040 |
Why?
|
| Chorion | 1 | 1997 | 117 | 0.040 |
Why?
|
| Middle Aged | 11 | 2016 | 213241 | 0.040 |
Why?
|
| Life Style | 1 | 1988 | 3833 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 1996 | 9 | 0.040 |
Why?
|
| Cations, Divalent | 2 | 2009 | 166 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8939 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1224 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 96 | 0.040 |
Why?
|
| Golgi Apparatus | 3 | 1975 | 410 | 0.040 |
Why?
|
| Joint Diseases | 2 | 1994 | 479 | 0.040 |
Why?
|
| Genomic Imprinting | 1 | 1998 | 331 | 0.040 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1996 | 115 | 0.040 |
Why?
|
| Mustard Compounds | 1 | 2015 | 4 | 0.030 |
Why?
|
| USSR | 1 | 1995 | 21 | 0.030 |
Why?
|
| Arthropod Vectors | 1 | 1995 | 6 | 0.030 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 261 | 0.030 |
Why?
|
| Communism | 1 | 1995 | 8 | 0.030 |
Why?
|
| Personnel, Hospital | 1 | 1998 | 283 | 0.030 |
Why?
|
| Flight, Animal | 1 | 1995 | 12 | 0.030 |
Why?
|
| Musculoskeletal System | 1 | 1998 | 175 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8430 | 0.030 |
Why?
|
| Marine Biology | 1 | 1995 | 18 | 0.030 |
Why?
|
| Hemangioendothelioma | 1 | 1997 | 121 | 0.030 |
Why?
|
| Disulfides | 6 | 1979 | 457 | 0.030 |
Why?
|
| Protein Folding | 2 | 1998 | 840 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 53250 | 0.030 |
Why?
|
| Phenylpropionates | 1 | 2015 | 30 | 0.030 |
Why?
|
| Vagotomy | 1 | 1976 | 83 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 1998 | 202 | 0.030 |
Why?
|
| Chemistry | 7 | 1977 | 352 | 0.030 |
Why?
|
| Camurati-Engelmann Syndrome | 1 | 1995 | 2 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 1993 | 5136 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 2008 | 211 | 0.030 |
Why?
|
| Chemical Phenomena | 7 | 1977 | 518 | 0.030 |
Why?
|
| Heme | 1 | 1998 | 306 | 0.030 |
Why?
|
| Tenotomy | 1 | 2015 | 49 | 0.030 |
Why?
|
| Homicide | 1 | 1998 | 287 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2002 | 8856 | 0.030 |
Why?
|
| Duodenal Ulcer | 1 | 1976 | 125 | 0.030 |
Why?
|
| Genes, src | 1 | 1995 | 52 | 0.030 |
Why?
|
| Ixodes | 1 | 1995 | 39 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2004 | 3701 | 0.030 |
Why?
|
| Borrelia | 1 | 1995 | 67 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 1991 | 4370 | 0.030 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 799 | 0.030 |
Why?
|
| Genomic Library | 2 | 1992 | 193 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 1620 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2002 | 3712 | 0.030 |
Why?
|
| Genes, fos | 1 | 1995 | 183 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2001 | 1005 | 0.030 |
Why?
|
| Mannose | 2 | 1990 | 124 | 0.030 |
Why?
|
| Immunologic Techniques | 3 | 1990 | 219 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 146 | 0.030 |
Why?
|
| Zinc | 1 | 1999 | 683 | 0.030 |
Why?
|
| Flagellin | 1 | 1995 | 125 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 3 | 2004 | 391 | 0.030 |
Why?
|
| Minerals | 1 | 1996 | 267 | 0.030 |
Why?
|
| Decidua | 1 | 1995 | 86 | 0.030 |
Why?
|
| Receptor, Notch2 | 1 | 2015 | 89 | 0.030 |
Why?
|
| Tropocollagen | 3 | 1972 | 4 | 0.030 |
Why?
|
| Triamcinolone Acetonide | 1 | 2015 | 101 | 0.030 |
Why?
|
| Fetus | 3 | 1993 | 1880 | 0.030 |
Why?
|
| Nobel Prize | 1 | 1974 | 49 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2015 | 2718 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 1861 | 0.030 |
Why?
|
| Antibodies, Bacterial | 2 | 2001 | 1470 | 0.030 |
Why?
|
| Cyanogen Bromide | 2 | 1986 | 73 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 1998 | 3850 | 0.030 |
Why?
|
| Research | 3 | 1996 | 1999 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1994 | 335 | 0.030 |
Why?
|
| Paintings | 1 | 1995 | 101 | 0.030 |
Why?
|
| Mifepristone | 1 | 2015 | 150 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1998 | 912 | 0.030 |
Why?
|
| Pregnancy | 2 | 2008 | 29140 | 0.030 |
Why?
|
| Eye Neoplasms | 1 | 1996 | 312 | 0.030 |
Why?
|
| Phenylalanine | 2 | 1993 | 365 | 0.030 |
Why?
|
| Hypertrophy | 2 | 1993 | 569 | 0.030 |
Why?
|
| Hybridization, Genetic | 1 | 1994 | 109 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1998 | 1472 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 56392 | 0.030 |
Why?
|
| Neoplasms | 2 | 2000 | 21675 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1995 | 295 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1994 | 203 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 379 | 0.030 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 1993 | 30 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2850 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 807 | 0.030 |
Why?
|
| Integrin alpha1beta1 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Health Facility Closure | 1 | 1993 | 18 | 0.030 |
Why?
|
| Models, Structural | 2 | 1971 | 361 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 405 | 0.030 |
Why?
|
| Trophoblasts | 1 | 1995 | 215 | 0.030 |
Why?
|
| Open Reading Frames | 3 | 2003 | 811 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 302 | 0.030 |
Why?
|
| Microscopy, Video | 2 | 2005 | 245 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2013 | 64 | 0.030 |
Why?
|
| Body Weight | 1 | 2004 | 4670 | 0.030 |
Why?
|
| Ecology | 1 | 1993 | 105 | 0.030 |
Why?
|
| Embryo Implantation | 1 | 1995 | 272 | 0.030 |
Why?
|
| Nondisjunction, Genetic | 1 | 1992 | 24 | 0.030 |
Why?
|
| Bone Lengthening | 1 | 1992 | 19 | 0.030 |
Why?
|
| Ovary | 1 | 1997 | 980 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 2 | 2009 | 1081 | 0.030 |
Why?
|
| Urography | 1 | 1994 | 313 | 0.030 |
Why?
|
| Pregnancy Proteins | 1 | 1994 | 229 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 1976 | 599 | 0.030 |
Why?
|
| Oocytes | 1 | 1997 | 1186 | 0.030 |
Why?
|
| Military Personnel | 1 | 2001 | 1133 | 0.030 |
Why?
|
| Birth Rate | 1 | 1993 | 170 | 0.030 |
Why?
|
| External Fixators | 1 | 1992 | 94 | 0.030 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2012 | 106 | 0.030 |
Why?
|
| Smad1 Protein | 1 | 2012 | 81 | 0.030 |
Why?
|
| Chromatography, Gel | 9 | 1975 | 670 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 1994 | 399 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 1078 | 0.030 |
Why?
|
| Genes, myc | 1 | 1993 | 399 | 0.030 |
Why?
|
| Peroxidases | 2 | 1972 | 138 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1998 | 1531 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1992 | 391 | 0.030 |
Why?
|
| Immunoassay | 2 | 1983 | 751 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2000 | 1911 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2004 | 17439 | 0.020 |
Why?
|
| Noonan Syndrome | 1 | 2012 | 122 | 0.020 |
Why?
|
| Crystallography | 1 | 1971 | 111 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2001 | 3585 | 0.020 |
Why?
|
| Skin Diseases | 2 | 1996 | 1066 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1997 | 1602 | 0.020 |
Why?
|
| Hexuronic Acids | 2 | 2001 | 144 | 0.020 |
Why?
|
| Calcineurin | 1 | 2012 | 226 | 0.020 |
Why?
|
| Glucuronic Acid | 2 | 2001 | 148 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1999 | 2037 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 19894 | 0.020 |
Why?
|
| Metaphase | 1 | 1991 | 151 | 0.020 |
Why?
|
| Microbial Collagenase | 6 | 1981 | 122 | 0.020 |
Why?
|
| Molecular Probes | 1 | 1993 | 315 | 0.020 |
Why?
|
| Metatarsal Bones | 1 | 2012 | 107 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2012 | 574 | 0.020 |
Why?
|
| Nucleic Acid Probes | 1 | 1990 | 9 | 0.020 |
Why?
|
| HIV Infections | 1 | 1997 | 16715 | 0.020 |
Why?
|
| Fractures, Ununited | 1 | 1992 | 165 | 0.020 |
Why?
|
| Culture Techniques | 3 | 1995 | 553 | 0.020 |
Why?
|
| Serine Endopeptidases | 2 | 2010 | 1073 | 0.020 |
Why?
|
| Lung | 3 | 2008 | 9858 | 0.020 |
Why?
|
| Aged | 6 | 2016 | 163178 | 0.020 |
Why?
|
| Genome, Human | 1 | 2004 | 4418 | 0.020 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1993 | 255 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 1990 | 209 | 0.020 |
Why?
|
| Organ Culture Techniques | 2 | 2004 | 813 | 0.020 |
Why?
|
| Biological Evolution | 2 | 1988 | 1079 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 1995 | 1552 | 0.020 |
Why?
|
| Agoraphobia | 1 | 1990 | 179 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 411 | 0.020 |
Why?
|
| Models, Molecular | 3 | 2010 | 5445 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1991 | 323 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 190 | 0.020 |
Why?
|
| Feces | 1 | 1996 | 1397 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 2004 | 475 | 0.020 |
Why?
|
| Economics, Medical | 1 | 1990 | 113 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2001 | 2217 | 0.020 |
Why?
|
| Germ-Line Mutation | 2 | 2012 | 1787 | 0.020 |
Why?
|
| Cosmids | 1 | 1989 | 107 | 0.020 |
Why?
|
| Collagen Type VII | 1 | 2009 | 20 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2010 | 273 | 0.020 |
Why?
|
| Connective Tissue Cells | 1 | 1989 | 55 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 1995 | 1157 | 0.020 |
Why?
|
| Heat-Shock Response | 1 | 2010 | 163 | 0.020 |
Why?
|
| Tibial Fractures | 1 | 1992 | 269 | 0.020 |
Why?
|
| World Health Organization | 1 | 1995 | 1317 | 0.020 |
Why?
|
| Electricity | 1 | 2010 | 182 | 0.020 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2009 | 45 | 0.020 |
Why?
|
| Integrin alpha5beta1 | 1 | 2009 | 38 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 893 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 1993 | 669 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2010 | 179 | 0.020 |
Why?
|
| Myopia | 2 | 2004 | 253 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 2009 | 182 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 418 | 0.020 |
Why?
|
| Poly A | 1 | 1989 | 185 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1994 | 668 | 0.020 |
Why?
|
| Receptor, TIE-1 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Galactosides | 1 | 2008 | 52 | 0.020 |
Why?
|
| Consanguinity | 3 | 1996 | 455 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2012 | 600 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1994 | 1205 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2004 | 3445 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 204 | 0.020 |
Why?
|
| Cysts | 1 | 1993 | 678 | 0.020 |
Why?
|
| Integrin alpha2beta1 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2015 | 1950 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2002 | 2556 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1994 | 1173 | 0.020 |
Why?
|
| Models, Genetic | 3 | 2004 | 3492 | 0.020 |
Why?
|
| Estrogens | 1 | 1994 | 1563 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 491 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3550 | 0.020 |
Why?
|
| Family | 1 | 1998 | 3144 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1705 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 818 | 0.020 |
Why?
|
| Ultracentrifugation | 5 | 1974 | 182 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2009 | 488 | 0.020 |
Why?
|
| Risk Factors | 2 | 2009 | 72252 | 0.020 |
Why?
|
| Cell Communication | 1 | 1994 | 1621 | 0.020 |
Why?
|
| Cell Cycle | 1 | 1995 | 2963 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1707 | 0.020 |
Why?
|
| Health Occupations | 1 | 1988 | 224 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 2 | 1981 | 914 | 0.020 |
Why?
|
| Life Expectancy | 1 | 1993 | 1184 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 8300 | 0.020 |
Why?
|
| Anisotropy | 1 | 2010 | 1263 | 0.020 |
Why?
|
| Probability | 2 | 2008 | 2505 | 0.020 |
Why?
|
| Culture Media | 1 | 2008 | 909 | 0.020 |
Why?
|
| Genes, Recessive | 2 | 2001 | 641 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 1409 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 1969 | 316 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2009 | 709 | 0.020 |
Why?
|
| Linkage Disequilibrium | 2 | 2002 | 1996 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1988 | 395 | 0.020 |
Why?
|
| Chromatography, Affinity | 3 | 1998 | 549 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2013 | 1211 | 0.020 |
Why?
|
| Denmark | 1 | 1988 | 738 | 0.020 |
Why?
|
| Zebrafish | 1 | 2017 | 2995 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1783 | 0.020 |
Why?
|
| Gelatin | 1 | 1967 | 226 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2500 | 0.020 |
Why?
|
| Melanoma | 2 | 2002 | 5508 | 0.020 |
Why?
|
| Biological Assay | 1 | 2008 | 650 | 0.020 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 9440 | 0.020 |
Why?
|
| Hydroxyproline | 3 | 1973 | 116 | 0.020 |
Why?
|
| Carbon Radioisotopes | 3 | 1995 | 577 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1789 | 0.020 |
Why?
|
| Curriculum | 1 | 2018 | 3603 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2009 | 796 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 927 | 0.020 |
Why?
|
| Femur Head | 1 | 2007 | 301 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2002 | 1962 | 0.020 |
Why?
|
| Length of Stay | 1 | 1998 | 6311 | 0.020 |
Why?
|
| Carbohydrates | 2 | 1980 | 394 | 0.020 |
Why?
|
| Placenta | 1 | 1994 | 1699 | 0.020 |
Why?
|
| Epithelial Cells | 3 | 1993 | 3690 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 1975 | 77 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1985 | 306 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2004 | 96 | 0.020 |
Why?
|
| Densitometry | 3 | 1971 | 156 | 0.020 |
Why?
|
| Autopsy | 1 | 1988 | 1020 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 1990 | 862 | 0.020 |
Why?
|
| Adenosine Triphosphate | 3 | 1967 | 2029 | 0.020 |
Why?
|
| Chromatography | 3 | 1969 | 206 | 0.020 |
Why?
|
| Communication | 1 | 1998 | 3748 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2010 | 708 | 0.020 |
Why?
|
| Burns | 1 | 2015 | 1815 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 12954 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1999 | 3142 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 2004 | 231 | 0.010 |
Why?
|
| Tritium | 2 | 1995 | 745 | 0.010 |
Why?
|
| Brevican | 1 | 2003 | 4 | 0.010 |
Why?
|
| Neurocan | 1 | 2003 | 23 | 0.010 |
Why?
|
| Versicans | 1 | 2003 | 33 | 0.010 |
Why?
|
| Methods | 2 | 1974 | 1128 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2007 | 1263 | 0.010 |
Why?
|
| Decision Making | 1 | 1997 | 3887 | 0.010 |
Why?
|
| Employment | 1 | 1990 | 1132 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2003 | 112 | 0.010 |
Why?
|
| Neonatal Screening | 1 | 2008 | 590 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2007 | 3794 | 0.010 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2003 | 136 | 0.010 |
Why?
|
| Developing Countries | 1 | 1995 | 2815 | 0.010 |
Why?
|
| Rural Population | 1 | 1993 | 2207 | 0.010 |
Why?
|
| Radioimmunoassay | 4 | 1976 | 916 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1999 | 4260 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2004 | 290 | 0.010 |
Why?
|
| Tensile Strength | 1 | 2003 | 335 | 0.010 |
Why?
|
| Spectrophotometry | 3 | 1976 | 313 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2298 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 637 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2004 | 625 | 0.010 |
Why?
|
| Animals, Outbred Strains | 1 | 2001 | 21 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15526 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 676 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2009 | 1800 | 0.010 |
Why?
|
| Wnt2 Protein | 1 | 2001 | 28 | 0.010 |
Why?
|
| Polymerization | 1 | 1963 | 164 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 658 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2971 | 0.010 |
Why?
|
| Temporomandibular Joint | 1 | 2003 | 196 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 2002 | 127 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 2000 | 2183 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1965 | 645 | 0.010 |
Why?
|
| Enterobacter | 2 | 1971 | 46 | 0.010 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2003 | 250 | 0.010 |
Why?
|
| Plastic Embedding | 1 | 2001 | 8 | 0.010 |
Why?
|
| Base Composition | 1 | 1981 | 293 | 0.010 |
Why?
|
| Hydroxylation | 2 | 1979 | 141 | 0.010 |
Why?
|
| Auditory Threshold | 1 | 2003 | 364 | 0.010 |
Why?
|
| Urine | 1 | 2003 | 370 | 0.010 |
Why?
|
| Cathepsin K | 1 | 2000 | 67 | 0.010 |
Why?
|
| Cathepsin D | 1 | 2000 | 61 | 0.010 |
Why?
|
| Pyroglutamyl-Peptidase I | 1 | 1980 | 3 | 0.010 |
Why?
|
| Immunodiffusion | 3 | 1975 | 163 | 0.010 |
Why?
|
| Frizzled Receptors | 1 | 2001 | 91 | 0.010 |
Why?
|
| Forelimb | 1 | 2001 | 122 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1981 | 290 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2001 | 147 | 0.010 |
Why?
|
| Histidine | 1 | 2001 | 312 | 0.010 |
Why?
|
| Capsules | 1 | 2001 | 196 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 2002 | 2184 | 0.010 |
Why?
|
| Urban Population | 1 | 1988 | 2021 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 2 | 1971 | 170 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 183 | 0.010 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 1060 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2012 | 2134 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 960 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 733 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10251 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2000 | 176 | 0.010 |
Why?
|
| Lasers | 1 | 2004 | 949 | 0.010 |
Why?
|
| Neuralgia | 1 | 1986 | 570 | 0.010 |
Why?
|
| Computational Biology | 1 | 2012 | 3515 | 0.010 |
Why?
|
| Indoles | 1 | 2008 | 1841 | 0.010 |
Why?
|
| Genetic Code | 1 | 1980 | 154 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 2001 | 299 | 0.010 |
Why?
|
| Macrophages | 1 | 2014 | 5651 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2004 | 1252 | 0.010 |
Why?
|
| Glycopeptides | 1 | 1981 | 226 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 491 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3504 | 0.010 |
Why?
|
| Spheroids, Cellular | 1 | 2001 | 348 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1008 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2000 | 258 | 0.010 |
Why?
|
| Autoantigens | 1 | 2004 | 892 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 2001 | 450 | 0.010 |
Why?
|
| Protein Denaturation | 3 | 1970 | 237 | 0.010 |
Why?
|
| Ribs | 1 | 2001 | 252 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 95 | 0.010 |
Why?
|
| Synovial Membrane | 1 | 2002 | 506 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2012 | 3439 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1999 | 258 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2000 | 311 | 0.010 |
Why?
|
| Sheep | 3 | 1980 | 1437 | 0.010 |
Why?
|
| Sheep Diseases | 1 | 1978 | 18 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1999 | 457 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2001 | 478 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 1436 | 0.010 |
Why?
|
| Tooth Socket | 1 | 1999 | 115 | 0.010 |
Why?
|
| Cattle Diseases | 1 | 1978 | 53 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2003 | 1209 | 0.010 |
Why?
|
| Cell Membrane | 2 | 2000 | 3749 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 1997 | 107 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 1525 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2001 | 675 | 0.010 |
Why?
|
| Hemin | 1 | 1998 | 50 | 0.010 |
Why?
|
| Immune Sera | 1 | 1978 | 641 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1983 | 1185 | 0.010 |
Why?
|
| Methylcellulose | 2 | 1967 | 37 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 654 | 0.010 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 1998 | 88 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 2003 | 1269 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2002 | 2085 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 2241 | 0.010 |
Why?
|
| Matrix Metalloproteinase 15 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1997 | 50 | 0.010 |
Why?
|
| Matrix Metalloproteinase 16 | 1 | 1997 | 4 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1975 | 363 | 0.010 |
Why?
|
| Glycine | 2 | 1971 | 670 | 0.010 |
Why?
|
| Microcirculation | 1 | 2002 | 1287 | 0.010 |
Why?
|
| Clone Cells | 1 | 2001 | 1692 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 1998 | 191 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1988 | 2528 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 1060 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2003 | 748 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2001 | 690 | 0.010 |
Why?
|
| Microchemistry | 1 | 1996 | 57 | 0.010 |
Why?
|
| Electrophoresis, Disc | 3 | 1971 | 70 | 0.010 |
Why?
|
| Incidence | 2 | 2008 | 20948 | 0.010 |
Why?
|
| Bone Matrix | 1 | 1997 | 113 | 0.010 |
Why?
|
| Genomics | 1 | 2012 | 5714 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 1899 | 0.010 |
Why?
|
| Cataract | 1 | 2003 | 834 | 0.010 |
Why?
|
| Cytoplasm | 3 | 1976 | 1536 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1997 | 318 | 0.010 |
Why?
|
| Movement | 1 | 2003 | 1471 | 0.010 |
Why?
|
| Gastric Juice | 1 | 1976 | 63 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 2 | 1973 | 131 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 1613 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1885 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1995 | 116 | 0.010 |
Why?
|
| Osteopontin | 1 | 1997 | 294 | 0.010 |
Why?
|
| TATA Box | 1 | 1995 | 128 | 0.010 |
Why?
|
| Acetylglucosamine | 1 | 1977 | 191 | 0.010 |
Why?
|
| Health Expenditures | 1 | 1988 | 2348 | 0.010 |
Why?
|
| Fishes | 2 | 1969 | 569 | 0.010 |
Why?
|
| Sepharose | 1 | 1995 | 108 | 0.010 |
Why?
|
| Vitellogenins | 1 | 1994 | 22 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1977 | 415 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1995 | 99 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 2 | 1974 | 87 | 0.010 |
Why?
|
| Integrin alpha6 | 1 | 1994 | 30 | 0.010 |
Why?
|
| Isomerases | 1 | 1974 | 56 | 0.010 |
Why?
|
| Belgium | 1 | 1974 | 103 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 1402 | 0.010 |
Why?
|
| Desmosomes | 1 | 1994 | 73 | 0.010 |
Why?
|
| Chemical Precipitation | 3 | 1974 | 179 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1997 | 599 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 3268 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1975 | 251 | 0.010 |
Why?
|
| Pseudomonas | 1 | 1974 | 117 | 0.010 |
Why?
|
| Marfan Syndrome | 1 | 1996 | 240 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1995 | 448 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 1994 | 135 | 0.010 |
Why?
|
| Vacuoles | 1 | 1975 | 229 | 0.010 |
Why?
|
| Alkylation | 1 | 1973 | 86 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1997 | 607 | 0.010 |
Why?
|
| Minisatellite Repeats | 1 | 1994 | 165 | 0.010 |
Why?
|
| Citrates | 1 | 1973 | 131 | 0.010 |
Why?
|
| Mercaptoethanol | 1 | 1973 | 64 | 0.010 |
Why?
|
| England | 1 | 1974 | 522 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2001 | 3547 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1993 | 107 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2001 | 3617 | 0.010 |
Why?
|
| Comorbidity | 1 | 2008 | 10380 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15518 | 0.010 |
Why?
|
| Thymidine | 1 | 1993 | 310 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1976 | 609 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 1998 | 2011 | 0.010 |
Why?
|
| Keratins | 1 | 1994 | 515 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 803 | 0.010 |
Why?
|
| Plants | 2 | 1972 | 316 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 1976 | 590 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1998 | 1586 | 0.010 |
Why?
|
| Prolactin | 1 | 1994 | 668 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 1994 | 279 | 0.010 |
Why?
|
| Xenopus | 1 | 1994 | 712 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2440 | 0.010 |
Why?
|
| Retroviridae | 1 | 1995 | 913 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1998 | 3128 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2001 | 2378 | 0.010 |
Why?
|
| Bone Wires | 1 | 1992 | 122 | 0.010 |
Why?
|
| Autoradiography | 1 | 1993 | 745 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10940 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 1731 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1994 | 867 | 0.010 |
Why?
|
| Sweden | 1 | 1974 | 1341 | 0.010 |
Why?
|
| Cystine | 1 | 1972 | 95 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 1998 | 1121 | 0.010 |
Why?
|
| Swine | 2 | 1973 | 5909 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2008 | 39001 | 0.010 |
Why?
|
| Carboxy-Lyases | 1 | 1971 | 90 | 0.010 |
Why?
|
| Gastrectomy | 1 | 1976 | 663 | 0.010 |
Why?
|
| Borates | 1 | 1970 | 21 | 0.010 |
Why?
|
| Tromethamine | 1 | 1970 | 31 | 0.010 |
Why?
|
| Mosaicism | 1 | 1994 | 441 | 0.010 |
Why?
|
| Ribosomal Proteins | 1 | 1993 | 360 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1994 | 669 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 432 | 0.010 |
Why?
|
| Panic | 1 | 1990 | 105 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1970 | 313 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1995 | 1213 | 0.010 |
Why?
|
| Bromides | 1 | 1969 | 20 | 0.010 |
Why?
|
| Hydrolases | 1 | 1971 | 139 | 0.010 |
Why?
|
| Catalase | 1 | 1970 | 221 | 0.010 |
Why?
|
| Haplorhini | 1 | 1971 | 548 | 0.010 |
Why?
|
| Contracture | 1 | 1992 | 223 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 77410 | 0.010 |
Why?
|
| Cyanides | 1 | 1969 | 83 | 0.010 |
Why?
|
| Iron | 1 | 1998 | 1774 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1970 | 624 | 0.010 |
Why?
|
| Saccharomyces | 1 | 1969 | 65 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1994 | 1061 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 4974 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1971 | 589 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3421 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1988 | 278 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1989 | 25032 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1971 | 1422 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1677 | 0.000 |
Why?
|
| Carbon Isotopes | 3 | 1973 | 468 | 0.000 |
Why?
|
| Tail | 1 | 1967 | 97 | 0.000 |
Why?
|
| Phosphates | 1 | 1970 | 784 | 0.000 |
Why?
|
| Receptors, Estrogen | 1 | 1994 | 2190 | 0.000 |
Why?
|
| DNA Replication | 1 | 1993 | 1399 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4848 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1971 | 1125 | 0.000 |
Why?
|
| Polymers | 1 | 1973 | 1621 | 0.000 |
Why?
|
| Drosophila | 1 | 1993 | 1494 | 0.000 |
Why?
|
| Serine | 1 | 1969 | 825 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 40545 | 0.000 |
Why?
|
| Testosterone | 1 | 1994 | 2297 | 0.000 |
Why?
|
| Carcinoma | 1 | 1976 | 2375 | 0.000 |
Why?
|
| Immunoelectrophoresis | 2 | 1975 | 110 | 0.000 |
Why?
|
| Amidinotransferases | 1 | 1963 | 11 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2001 | 21733 | 0.000 |
Why?
|
| Thyroid Neoplasms | 1 | 1976 | 2282 | 0.000 |
Why?
|
| Ammonium Sulfate | 2 | 1972 | 29 | 0.000 |
Why?
|
| Mitochondria | 1 | 1976 | 3513 | 0.000 |
Why?
|
| Creatine | 1 | 1963 | 421 | 0.000 |
Why?
|
| United States | 2 | 2001 | 69859 | 0.000 |
Why?
|
| Myocardium | 1 | 1993 | 4775 | 0.000 |
Why?
|
| Heart | 1 | 1993 | 4460 | 0.000 |
Why?
|
| X-Ray Diffraction | 1 | 1980 | 420 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 57744 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1963 | 962 | 0.000 |
Why?
|
| Cell Nucleus | 2 | 1976 | 2969 | 0.000 |
Why?
|
| Creatinine | 1 | 1963 | 1918 | 0.000 |
Why?
|
| Mammals | 1 | 1963 | 1143 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1976 | 75 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1978 | 561 | 0.000 |
Why?
|
| Anxiety | 1 | 1990 | 4288 | 0.000 |
Why?
|
| Carbodiimides | 1 | 1975 | 11 | 0.000 |
Why?
|
| Iodides | 1 | 1975 | 41 | 0.000 |
Why?
|
| Intramolecular Lyases | 1 | 1974 | 11 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1975 | 124 | 0.000 |
Why?
|
| Glutaral | 1 | 1975 | 78 | 0.000 |
Why?
|
| Succinimides | 1 | 1975 | 79 | 0.000 |
Why?
|
| Calcitonin | 1 | 1976 | 336 | 0.000 |
Why?
|
| Chymotrypsin | 1 | 1974 | 149 | 0.000 |
Why?
|
| Indicators and Reagents | 1 | 1975 | 462 | 0.000 |
Why?
|
| Computers | 1 | 1976 | 602 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2001 | 35409 | 0.000 |
Why?
|
| Peptide Biosynthesis | 1 | 1973 | 55 | 0.000 |
Why?
|
| gamma-Globulins | 1 | 1972 | 124 | 0.000 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1975 | 482 | 0.000 |
Why?
|
| Amines | 1 | 1974 | 276 | 0.000 |
Why?
|
| Anura | 1 | 1972 | 85 | 0.000 |
Why?
|
| Lactones | 1 | 1974 | 329 | 0.000 |
Why?
|
| Aldehydes | 1 | 1972 | 167 | 0.000 |
Why?
|
| Detergents | 1 | 1972 | 230 | 0.000 |
Why?
|
| Optical Rotatory Dispersion | 1 | 1970 | 10 | 0.000 |
Why?
|
| Pyruvates | 1 | 1971 | 87 | 0.000 |
Why?
|
| Hydroxybutyrates | 1 | 1971 | 82 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1975 | 1035 | 0.000 |
Why?
|
| Hospitalization | 1 | 1990 | 10259 | 0.000 |
Why?
|
| Guanidines | 1 | 1971 | 193 | 0.000 |
Why?
|
| Lactates | 1 | 1971 | 431 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1992 | 15281 | 0.000 |
Why?
|
| Urea | 1 | 1971 | 450 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1976 | 2924 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 20827 | 0.000 |
Why?
|
| Lysine | 1 | 1973 | 1007 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1976 | 2455 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1970 | 1351 | 0.000 |
Why?
|
| Diet | 1 | 1963 | 7930 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1975 | 4561 | 0.000 |
Why?
|
| Pyridines | 1 | 1973 | 2827 | 0.000 |
Why?
|